You can buy or sell RUBY and other stocks, options, ETFs, and crypto commission-free!
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
Expected Nov 12, Pre-Market